Login Register Cart 0
Generic placeholder image

Current Alzheimer Research

Editor-in-Chief

ISSN (Print): 1567-2050
ISSN (Online): 1875-5828

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Pharmacological Management of Dysphagia in Patients with Alzheimer’s Disease: A Narrative Review

Author(s): Chien-Hsun Li, Sun-Wung Hsieh, Poyin Huang, Hsiu-Yueh Liu, Chun-Hung Chen* and Chih-Hsing Hung*

Volume 19, Issue 11, 2022

Published on: 27 December, 2022

Page: [743 - 753] Pages: 11

DOI: 10.2174/1567205020666221130091507

Price: $65

Abstract

Alzheimer’s disease (AD) and dysphagia are important health and socioeconomic problems in the aging population. Currently, the medical treatment of dysphagia in AD patients remains insufficient, and there are significant gaps in the management and clinical needs to postpone tube feeding. Literatures published over the last 30 years were searched in the PubMed and Embase databases. All relevant and promising pharmacological management studies were included. Because of the heterogeneity in design and methodology, only narrative reports were mentioned. Nine studies were included with two case reports, two case series, and two observational and three randomized controlled trials. The key approaches and clinical problems related to dysphagia include onset pattern, dementia stage, review of offending drugs and polypharmacy, and comorbidities (cerebrovascular disease, hypertension, parkinsonism, depression, and anorexia). The corresponding strategies of pharmacological treatments are further proposed and discussed comprehensively, with transient receptor potential channel modulators as promising treatment. With the integration of adequate and potential pharmacomanagement, AD patients with dysphagia can achieve a good prognosis and postpone tube feeding to maintain a better quality of life. More rigorous studies are needed to verify the effectiveness of innovative strategies and develop targets for neurostimulation.

Next »
[1]
Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol 2011; 7(3): 137-52.
[http://dx.doi.org/10.1038/nrneurol.2011.2] [PMID: 21304480]
[2]
Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement 2007; 3(3): 186-91.
[http://dx.doi.org/10.1016/j.jalz.2007.04.381] [PMID: 19595937]
[3]
Alzheimer’s Association. 2021 Alzheimer’s disease facts and figures. Alzheimers Dement 2021; 17(3): 327-406.
[http://dx.doi.org/10.1002/alz.12328] [PMID: 33756057]
[4]
Priefer BA, Robbins J. Eating changes in mild-stage Alzheimer’s disease: a pilot study. Dysphagia 1997; 12(4): 212-21.
[http://dx.doi.org/10.1007/PL00009539] [PMID: 9294942]
[5]
Ikeda M, Brown J, Holland AJ, Fukuhara R, Hodges JR. Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2002; 73(4): 371-6.
[http://dx.doi.org/10.1136/jnnp.73.4.371] [PMID: 12235302]
[6]
Boccardi V, Ruggiero C, Patriti A, Marano L. Diagnostic assessment and management of dysphagia in patients with Alzheimer’s disease. J Alzheimers Dis 2016; 50(4): 947-55.
[http://dx.doi.org/10.3233/JAD-150931] [PMID: 26836016]
[7]
Easterling CS, Robbins E. Dementia and dysphagia. Geriatr Nurs 2008; 29(4): 275-85.
[http://dx.doi.org/10.1016/j.gerinurse.2007.10.015] [PMID: 18694703]
[8]
Sura L, Madhavan A, Carnaby G, Crary MA. Dysphagia in the elderly: Management and nutritional considerations. Clin Interv Aging 2012; 7: 287-98.
[PMID: 22956864]
[9]
Kai K, Hashimoto M, Amano K, Tanaka H, Fukuhara R, Ikeda M. Relationship between eating disturbance and dementia severity in patients with Alzheimer’s disease. PLoS One 2015; 10(8): e0133666.
[http://dx.doi.org/10.1371/journal.pone.0133666] [PMID: 26266531]
[10]
Volicer L, Seltzer B, Rheaume Y, et al. Eating difficulties in patients with probable dementia of the Alzheimer type. J Geriatr Psychiatry Neurol 1989; 2(4): 188-95.
[http://dx.doi.org/10.1177/089198878900200404] [PMID: 2483945]
[11]
Chouinard J, Lavigne E, Villeneuve C. Weight loss, dysphagia, and outcome in advanced dementia. Dysphagia 1998; 13(3): 151-5.
[http://dx.doi.org/10.1007/PL00009565] [PMID: 9633155]
[12]
Wirth R, Dziewas R, Beck AM, et al. Oropharyngeal dysphagia in older persons - from pathophysiology to adequate intervention: a review and summary of an international expert meeting. Clin Interv Aging 2016; 11: 189-208.
[http://dx.doi.org/10.2147/CIA.S97481] [PMID: 26966356]
[13]
De Stefano A, Di Giovanni P, Kulamarva G, et al. Oropharyngeal dysphagia in elderly population suffering from mild cognitive impairment and mild dementia: Understanding the link. Am J Otolaryngol 2020; 41(4): 102501.
[http://dx.doi.org/10.1016/j.amjoto.2020.102501] [PMID: 32409161]
[14]
Humbert IA, McLaren DG, Kosmatka K, et al. Early deficits in cortical control of swallowing in Alzheimer’s disease. J Alzheimers Dis 2010; 19(4): 1185-97.
[http://dx.doi.org/10.3233/JAD-2010-1316] [PMID: 20308785]
[15]
Özsürekci C, Arslan SS, Demir N, et al. Timing of dysphagia screening in Alzheimer’s dementia. JPEN J Parenter Enteral Nutr 2020; 44(3): 516-24.
[http://dx.doi.org/10.1002/jpen.1664] [PMID: 31172554]
[16]
Alagiakrishnan K, Bhanji RA, Kurian M. Evaluation and management of oropharyngeal dysphagia in different types of dementia: A systematic review. Arch Gerontol Geriatr 2013; 56(1): 1-9.
[http://dx.doi.org/10.1016/j.archger.2012.04.011] [PMID: 22608838]
[17]
Feinberg MJ, Ekberg O, Segall L, Tully J. Deglutition in elderly patients with dementia: findings of videofluorographic evaluation and impact on staging and management. Radiology 1992; 183(3): 811-4.
[http://dx.doi.org/10.1148/radiology.183.3.1584939] [PMID: 1584939]
[18]
Homer J, Alberts MJ, Dawson DV, Cook GM. Swallowing in Alzheimer’s disease. Alzheimer Dis Assoc Disord 1994; 8(3): 177-89.
[http://dx.doi.org/10.1097/00002093-199408030-00004] [PMID: 7986487]
[19]
Winchester J, Winchester CG. The five systems of dysphagia: MCI to the AD spectrum of disorders. Perspect ASHA Spec Interest Groups 2016; 1(15): 37-52.
[http://dx.doi.org/10.1044/persp1.SIG15.37]
[20]
Devons CAJ. Comprehensive geriatric assessment: Making the most of the aging years. Curr Opin Clin Nutr Metab Care 2002; 5(1): 19-24.
[http://dx.doi.org/10.1097/00075197-200201000-00004] [PMID: 11790944]
[21]
Warnecke T, Dziewas R, Wirth R, Bauer JM, Prell T. Dysphagia from a neurogeriatric point of view. Z Gerontol Geriatr 2019; 52(4): 330-5.
[http://dx.doi.org/10.1007/s00391-019-01563-x] [PMID: 31139962]
[22]
Thiyagalingam S, Kulinski AE, Thorsteinsdottir B, Shindelar KL, Takahashi PY. Dysphagia in older adults. Mayo Clin Proc 2021; 96(2): 488-97.
[http://dx.doi.org/10.1016/j.mayocp.2020.08.001] [PMID: 33549267]
[23]
Logemann JA, Gensler G, Robbins J, et al. A randomized study of three interventions for aspiration of thin liquids in patients with dementia or Parkinson’s disease. J Speech Lang Hear Res 2008; 51(1): 173-83.
[http://dx.doi.org/10.1044/1092-4388(2008/013)] [PMID: 18230864]
[24]
Chen LL, Li H, Lin R, et al. Effects of a feeding intervention in patients with Alzheimer’s disease and dysphagia. J Clin Nurs 2016; 25(5-6): 699-707.
[http://dx.doi.org/10.1111/jocn.13013] [PMID: 26420351]
[25]
Bautmans I, Demarteau J, Cruts B, Geriatrics J, Mets T. Dysphagia in elderly nursing home residents with severe cognitive impairment can be attenuated by cervical spine mobilization. J Rehabil Med 2008; 40(9): 755-60.
[http://dx.doi.org/10.2340/16501977-0243] [PMID: 18843429]
[26]
Anis MK, Abid S, Jafri W, et al. Acceptability and outcomes of the Percutaneous Endoscopic Gastrostomy (PEG) tube placement- patients’ and care givers’ perspectives. BMC Gastroenterol 2006; 6(1): 37.
[http://dx.doi.org/10.1186/1471-230X-6-37] [PMID: 17125502]
[27]
Peck A, Cohen CE, Mulvihill MN. Long-term enteral feeding of aged demented nursing home patients. J Am Geriatr Soc 1990; 38(11): 1195-8.
[http://dx.doi.org/10.1111/j.1532-5415.1990.tb01498.x] [PMID: 2123217]
[28]
Sanders DS, Carter MJ, D’Silva J, James G, Bolton RP, Bardhan KD. Survival analysis in percutaneous endoscopic gastrostomy feeding: a worse outcome in patients with dementia. Am J Gastroenterol 2000; 95(6): 1472-5.
[http://dx.doi.org/10.1111/j.1572-0241.2000.02079.x] [PMID: 10894581]
[29]
Wada H, Nakajoh K, Satoh-Nakagawa T, et al. Risk factors of aspiration pneumonia in Alzheimer’s disease patients. Gerontology 2001; 47(5): 271-6.
[http://dx.doi.org/10.1159/000052811] [PMID: 11490146]
[30]
Yamaguchi H, Maki Y, Maki Y. Tube feeding can be discontinued by taking dopamine agonists and angiotensin-converting enzyme inhibitors in the advanced stages of dementia. J Am Geriatr Soc 2010; 58(10): 2035-6.
[http://dx.doi.org/10.1111/j.1532-5415.2010.03086.x] [PMID: 20929480]
[31]
Sokoloff LG, Pavlakovic R. Neuroleptic-induced dysphagia. Dysphagia 1997; 12(4): 177-9.
[http://dx.doi.org/10.1007/PL00009533] [PMID: 9294935]
[32]
Mastroianni PC, Forgerini M. Drug administration adjustments for elderly patients with dysphagia: A case report. Dement Neuropsychol 2018; 12(1): 97-100.
[http://dx.doi.org/10.1590/1980-57642018dn12-010015] [PMID: 29682241]
[33]
Sevilla C, Jiménez Caballero PE, Alfonso V, González-Adalid M. Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients? Dement Geriatr Cogn Disord 2009; 28(3): 196-205.
[http://dx.doi.org/10.1159/000236015] [PMID: 19738386]
[34]
Zarra J, Schmidt LP. 5.a.001 Treatment of Alzheimer’s disease: Rationale for combination therapy with galantamine and memantine. Eur Neuropsychopharmacol 2011; 21: S545.
[http://dx.doi.org/10.1016/S0924-977X(11)70887-2]
[35]
Blesa R, Ballard C, Orgogozo JM, Lane R, Thomas SK. Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease. Neurology 2007; 69(4, Supplement 1) (Suppl. 1): S23-8.
[http://dx.doi.org/10.1212/01.wnl.0000281848.25142.11] [PMID: 17646620]
[36]
Grossberg GT, Manes F, Allegri RF, et al. The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer’s disease taking cholinesterase inhibitors. CNS Drugs 2013; 27(6): 469-78.
[http://dx.doi.org/10.1007/s40263-013-0077-7] [PMID: 23733403]
[37]
Irving GF, Freund-Levi Y, Eriksdotter-Jönhagen M, et al. Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer’s disease: the omega-3 Alzheimer’s disease study. J Am Geriatr Soc 2009; 57(1): 11-7.
[http://dx.doi.org/10.1111/j.1532-5415.2008.02055.x] [PMID: 19054188]
[38]
Khoury R, Patel K, Gold J, Hinds S, Grossberg GT. Recent progress in the pharmacotherapy of Alzheimer’s disease. Drugs Aging 2017; 34(11): 811-20.
[http://dx.doi.org/10.1007/s40266-017-0499-x] [PMID: 29116600]
[39]
Blesa R. Factors that influence treatment outcomes, adherence and persistence with rivastigmine patch. Eur J Neurol 2012; 19: 853.
[40]
Calhoun A, King C, Khoury R, Grossberg GT. An evaluation of memantine ER + donepezil for the treatment of Alzheimer’s disease. Expert Opin Pharmacother 2018; 19(15): 1711-7.
[http://dx.doi.org/10.1080/14656566.2018.1519022] [PMID: 30244611]
[41]
Shin HW, Chung SJ. Drug-induced Parkinsonism. J Clin Neurol 2012; 8(1): 15-21.
[http://dx.doi.org/10.3988/jcn.2012.8.1.15] [PMID: 22523509]
[42]
Estevez-Fraga C, Zeun P, López-Sendón Moreno JL. Current methods for the treatment and prevention of drug-induced parkinsonism and tardive dyskinesia in the elderly. Drugs Aging 2018; 35(11): 959-71.
[http://dx.doi.org/10.1007/s40266-018-0590-y] [PMID: 30357723]
[43]
Friedman JH. Movement disorders induced by psychiatric drugs that do not block dopamine receptors. Parkinsonism Relat Disord 2020; 79: 60-4.
[http://dx.doi.org/10.1016/j.parkreldis.2020.08.031] [PMID: 32871538]
[44]
Umemoto G, Furuya H. Management of dysphagia in patients with Parkinson’s disease and related disorders. Intern Med 2020; 59(1): 7-14.
[http://dx.doi.org/10.2169/internalmedicine.2373-18] [PMID: 30996170]
[45]
White HK. Weight loss in advanced Alzheimer’s disease part II: Interventions. Ann Longterm Care 2004; 12(6): 34-8.
[46]
Boateng J. Drug delivery innovations to address global health challenges for pediatric and geriatric populations (through improvements in patient compliance). J Pharm Sci 2017; 106(11): 3188-98.
[http://dx.doi.org/10.1016/j.xphs.2017.07.009] [PMID: 28734784]
[47]
Jalili-Baleh L, Babaei E, Abdpour S, et al. A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer’s disease. Eur J Med Chem 2018; 152: 570-89.
[http://dx.doi.org/10.1016/j.ejmech.2018.05.004] [PMID: 29763806]
[48]
Zhang X, He X, Chen Q, Lu J, Rapposelli S, Pi R. A review on the hybrids of hydroxycinnamic acid as multi-target-directed ligands against Alzheimer’s disease. Bioorg Med Chem 2018; 26(3): 543-50.
[http://dx.doi.org/10.1016/j.bmc.2017.12.042] [PMID: 29310862]
[49]
Ambure P, Bhat J, Puzyn T, Roy K. Identifying natural compounds as multi-target-directed ligands against Alzheimer’s disease: an in silico approach. J Biomol Struct Dyn 2019; 37(5): 1282-306.
[http://dx.doi.org/10.1080/07391102.2018.1456975] [PMID: 29578387]
[50]
Banner KH, Igney F, Poll C. TRP channels: Emerging targets for respiratory disease. Pharmacol Ther 2011; 130(3): 371-84.
[http://dx.doi.org/10.1016/j.pharmthera.2011.03.005] [PMID: 21420429]
[51]
Hossain MZ, Ando H, Unno S, Kitagawa J. Targeting chemosensory ion channels in peripheral swallowing-related regions for the management of oropharyngeal dysphagia. Int J Mol Sci 2020; 21(17): 6214.
[http://dx.doi.org/10.3390/ijms21176214] [PMID: 32867366]
[52]
Tomsen N, Alvarez-Berdugo D, Rofes L, et al. A randomized clinical trial on the acute therapeutic effect of TRPA1 and TRPM8 agonists in patients with oropharyngeal dysphagia. Neurogastroenterol Motil 2020; 32(6): e13821.
[http://dx.doi.org/10.1111/nmo.13821] [PMID: 32064725]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy